Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer
Mismatch repair deficient (MMRd) tumors harbor thousands of somatic mutations enriched for insertionβdeletion (indels) conferring high sensitivity to β¦
This is an important milestone: mutagenic drugs can increase TMB and induce a dMMR-like genetic profile, but do not improve response to immunotherapy in pMMR CRC patients. Some evidence of TIME remodelling, but likely not in the direction needed fro response... www.sciencedirect.com/science/arti...
14.06.2025 05:23 β π 5 π 1 π¬ 0 π 0
Fishing for melanoma metastasis-initiating cells in lymph nodes
Nature Cancer - The complex nature of metastasis-initiating cells (MICs) has long hindered our understanding of how cancer spreads and how to prevent it. A study now identifies a potential MIC...
rdcu.be/emi9N
Fishing for Metastasis Initiating Cells (MICs): we summarize here a heroic effort from Christoph Klein and Melanie Werner-Klein labs, which describes a MIC population in lymph nodes and how these cells evade immune attack. #metastasis #melanoma #extracellularvesicles #cancerprevention
17.05.2025 08:25 β π 20 π 6 π¬ 0 π 0
#AACR25
26.04.2025 21:41 β π 1 π 0 π¬ 0 π 0
The size of the plenary hall is always inspiring. So many cancer researchers in one place!
26.04.2025 21:02 β π 0 π 0 π¬ 1 π 0
Fantastic talk by @karunamdphd.bsky.social! A comprehensive study investigating microenvironmental impact on young onset colorectal cancer.
26.04.2025 18:57 β π 1 π 0 π¬ 0 π 0
Ready to learn about dormancy at #AACR25
26.04.2025 17:32 β π 1 π 0 π¬ 1 π 0
Tumor metabolism is always a tough topic but the speakers at the microenvironment and metabolism session at #AACR25 are doing a great job making it accessible.
While many nutrients are absent in the area around the tumor. Some metabolites are far more abundant! How are tumors using these instead?
26.04.2025 15:34 β π 1 π 0 π¬ 0 π 0
Fantastic first session at #AACR25 on non-genetic drivers of metastasis!
While genetic drivers are important in establishing fitness, it is clear that they are not sufficient to lead to metastasis by themselves.
26.04.2025 13:54 β π 10 π 1 π¬ 0 π 0
Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes
Most phenotype-associated genetic variants map to noncoding regulatory regions of the human genome, but their mechanisms remain elusive in most cases. We developed a highly efficient strategy, Perturb...
Out today in @science.org!
What if you could chart cells' regulatory programs at unprecedented resolution?
In my work with Jorge Martin-Rufino from the @bloodgenes.bsky.social lab, we dissect the genomeβs control circuits and find where key genetic variation hides
bit.ly/3YhBMoO
03.04.2025 21:20 β π 51 π 17 π¬ 4 π 2
Regulation of metastatic organotropism
Metastasis is responsible for most cancer-related deaths. Different cancers have their
own preferential sites of metastases, a phenomenon termed metastatic organotropism.
The mechanisms underlying org...
Super nice review on metastasis organo-tropismβ¬οΈ the process where tumor cells preferentially spread to specific distant organs, and represents a critical aspect of cancer biology with profound implications for patient outcomes. #CDH1
www.cell.com/trends/cance...
29.03.2025 06:16 β π 13 π 5 π¬ 1 π 0
Figure 1 TFBomics of the E11.5 mouse embryo. (A) Schematic overview of the experimental design, detailing the tissues dissected from E11.5 JAX/Swiss mice and the targets profiled in each tissue using C&R LoV-U. (B) Left: Clustering of data according to Spearman's correlation. Black boxes highlight higher correlation or clustering according to the profiled factor, whereas red boxes highlight this between factors within the same tissue. IgG negative controls are highlighted in a gray box. Right: Overall data patterns shown by PCA. PC1 (58.7% of variance) separated some samples by the target factor (ellipses shaded by factor color code), while PC2 (9.7% of variance) typically separates the liver (marked with stars) from other tissues.
Construction of an atlas of transcription factor binding during mouse development identifies popular regulatory regions
Read this Techniques & Resources Article by @annanordin.bsky.social @gianlucazamba.bsky.social @claudiocantu81.bsky.social & co.: doi.org/10.1242/dev....
29.03.2025 09:51 β π 40 π 16 π¬ 0 π 1
Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anti-Cancer Cytotoxicity in Breast Cancer - by Aviad Ben Shmuel, Yael Gruper, Coral Halperin, Ruth Scherz-Shouval and colleagues doi.org/10.1158/2159...
11.03.2025 18:00 β π 18 π 4 π¬ 0 π 0
Ten simple rules for writing a response to reviewers
journals.plos.org/ploscompbiol...
02.03.2025 16:07 β π 60 π 20 π¬ 1 π 2
Long-range enhancer-controlled genes are hypersensitive to regulatory factor perturbations
www.cell.com/cell-genomic...
25.02.2025 17:38 β π 13 π 6 π¬ 0 π 0
Targeting Colorectal Cancer Liver Metastasis Through Repurposing Metabolic and Immune Inhibitors : A Theoretical Study https://www.biorxiv.org/content/10.1101/2025.02.12.637833v1
17.02.2025 02:55 β π 3 π 2 π¬ 0 π 0
The AAVantages of AAV in CRISPR Screens
Learn about the advantages of using AAV as a delivery method for CRISPR screens.
The in vivo option β why you should consider AAV for your next CRISPR screen. Find out in our latest blog post!
blog.addgene.org/aav...
05.02.2025 19:00 β π 3 π 1 π¬ 0 π 0
CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancer https://www.biorxiv.org/content/10.1101/2025.01.30.629925v1
01.02.2025 00:48 β π 4 π 1 π¬ 0 π 0
Diet links gut chemistry with cancer risk in C57Bl/6 mice and human colorectal cancer patients https://www.biorxiv.org/content/10.1101/2025.01.27.635083v1
28.01.2025 17:48 β π 3 π 1 π¬ 0 π 0
2 weeks until the deadline for our Diversity in Cancer Research summer internship program at Georgetown Lombardi. Amid the fear and chaos of this week, I want to be clear - we are committed to this program. Our non-govt funders are committed to this program. We're not going anywhere π§ͺπ§¬π©βπ¬
24.01.2025 18:09 β π 77 π 21 π¬ 0 π 4
Thank you for the opportunity to present our work and organizing a fantastic meeting!
21.01.2025 23:59 β π 1 π 0 π¬ 0 π 0
In this review, Kudelka et al. examine the unifying cellular and molecular principles that contribute to the development and progression of squamous cell carcinomas at different anatomical sites. #OpenAccess
Learn more here:
β‘οΈ tinyurl.com/gd351990
15.01.2025 22:16 β π 6 π 1 π¬ 0 π 0
Dealing With Being a Tumor Cell
How do cancer cells adapt to the stress of being cancer cells, with the constant stream of mutant and misfolded proteins? Thereβs more than one strategy, and therapeutically youβd like to know which is being used:
14.01.2025 20:55 β π 40 π 11 π¬ 3 π 2
Medicinal chemist interested in cancer and infectious disease (Fimbrion and WashU). Kinase, protease, GPCR, PDE and lectin inhibitor drug discovery. Antibacterial, antiviral, anthelmintic, anti-parasitic. Small molecule, peptide and carbohydrate.
Global association dedicated to improving the understanding & clinical management of inherited gastrointestinal cancer syndromes for affected families. #HereditaryGICancer
Visit us at cgaigc.com and also connect with us on LinkedIn, X and Instagram!
Director, Marc and Jennifer Lipschultz Precision Immunology Institute: https://icahn.mssm.edu/research/immunology
Harnessing the innate immune system for novel therapies against cancer & inflammatory diseases: https://www.meradlab.org/
Group leader at the Barts Cancer Institute, investigating non-genetic mechanisms of metastasis and therapy resistance
We study the drivers of cancer evolution from initiation to response to therapy. We are part of the Centre for Cancer Evolution at Barts Cancer Institute and the Francis Crick Institute in London, UK. Posts from Francesca
Biomedical Scientist interested in #Cancer #Metastasis Research | PhD applicant | Looking for Research Assistant positions in the US
https://www.linkedin.com/in/sara-susan-silva-de-fran%C3%A7a-140204204?trk=contact-info
Naxerova lab at @HMSGenetics. We study somatic evolution and cancer genetics.
We study how micro-environmental and epigenetic mechanisms drive cancer cells into dormancy. We seek to control this biology to prevent and treat metastasis. https://einsteinmed.edu/faculty/16974/julio-aguirre-ghiso
PhD student at the Institute of Genetics and Cancer, University of Edinburgh
We are a leading Cancer Research Institute within The University of Manchester, funded by Cancer Research UK (@cancerresearchuk.org)
https://www.cruk.manchester.ac.uk/
Thoracic oncologist at DKFZ Heidelberg & UniversitΓ€tsmedizin Mannheim | Liquid Biopsy and Single Cell Analysis Group π§¬π§« π«
Prof at U of Colorado SOM. Researcher in the evolutionary biology of cancer, AML, and aging. Completely dog-dependent. Waiting for the next puzzling result....
Weβre the world's leading independent cancer charity dedicated to saving lives through research, influence and information.
linktr.ee/cr_uk
Scientist. Group leader at the Sanger Institute, Cambridge UK. Somatic mutation and selection in normal tissues, cancer and ageing.
Assistant Prof, GI Oncologist @
Duke Cancer researching immunotherapy, metastasis, and the immune microenvironment.
#FirstGen. USouthFlorida alumnus. Tufts residency survivor.
Patients donβt fail treatments, treatments fail patients.
Opinions=mine
We study teeth! Motivated by dental anthropology & human evolution, powered by NSF. Science is for all. Posts by Dr. Kristin Krueger.
Biochemistry PhD student at McGill. Studies and loves talking about RTKs in lung cancer. Coffee and cafe lover. Also, black hole enthusiast.
The Australasian Metastasis Research Society (OzMRS) supports and promotes Australian researchers interested in studying cancer metastasis & metastatic disease.
Stanford, cell cycle, RB, cancer, SCLC, mouse models